Melissa Kaufman

Phase 3 CELLEBRATE trial testing regenerative stem cell-based therapy to improve urinary control for women

The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. 

Roger Dmochowski, MD, with Female Pelvic Medicine and Reconstructive Surgery Urology fellows Stephanie Gleicher, MD, MPH, left, who graduates in June, and Rosa Park, MD.

Urology fellowship program celebrated after 20 years

The urology fellowship training program focused on women’s urologic health and reconstruction, known as Female Pelvic Medicine and Reconstructive Surgery, is celebrating its 20th anniversary and graduating its 20th fellow in June at Vanderbilt University Medical Center.

Stimulation device helps patients with bladder disorders reprogram

A neurostimulator surgically implanted above the buttocks to reprogram how the bladder senses the filling of urine is helping patients with debilitating bladder and bowel disorders that are often life-limiting.

Physician volunteers assisting families of COVID patients

Physicians from all specialties across Vanderbilt University Medical Center are volunteering their time to communicate daily with family members of patients in the COVID-19 Intensive Care Unit.

Urology association honors Kaufman

Melissa Kaufman, M.D., Ph.D., associate professor of Urologic Surgery, received the 2017 Zimskind Award at the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU) Winter Meeting in Scottsdale, Arizona.

A smiling woman in her 50s in front of a rock wall.

VU study tracks urinary incontinence therapy

More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat.